XTalks

NOVEMBER 24, 2020

Unlike its competitors, Modern Meat’s products are made from real whole foods without any fillers, additives or preservatives. Rather than working in labs, Modern Meat’s chefs, many of whom are local, work in kitchens where they curate high-protein, nutrient-rich plant-based products without sacrificing the taste of meat.

Filler 105

Filler Production Protein Manufacturing 105

XTalks

MARCH 8, 2022

In 2019, Wishingrad decided to develop her own gluten-free, grain-free version of the staple. . But thanks to years of research and taste testing, Hertz went on to successfully develop her own craft beer brewed with gluten-free millet and buckwheat. Since then, the Holidaily Brewing Company has found massive success. Westbourne.

Branding 97

Branding Packaging Packaging Filler 97

XTalks

MAY 25, 2022

Ceramanet G, a bone void filler with the antibiotic gentamicin, fills bone voids and immediately begins bone healing with protection. Cerament G is a bone void filler treatment that can fill the gaps in the affected bones and simultaneously deliver the antibiotic gentamicin to reduce the risk of reinfection. mg/mL of cerament paste.

Filler 98

Filler Production Marketing Sales 98

The Pharma Data

NOVEMBER 4, 2020

(TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

Licensing 40

Licensing Licensing Dermatology Production 40

pharmaphorum

AUGUST 13, 2020

We see the dedication of healthcare workers – or of the shelf-filler in our local store – and we are moved to thank them and to make our own contribution. Something we want to receive and something we want to give. Each of us is touched by the countless acts of community kindness being shown to the vulnerable.

Branding 96

Branding Vaccination Vaccine Filler 96

The Pharma Data

DECEMBER 27, 2020

Current intraarticular anti-inflammatory treatments for OA have potentially toxic side effects and may lead to the destruction of cartilage filler proteins. SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Dec. About TLC599.

Trials 40

Trials Clinical Trials Clinical Trials Containment 40